Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes

被引:20
作者
Brod, Meryl
Christensen, Torsten
Bushnell, Donald
机构
[1] BROD GRP, Mill Valley, CA 94941 USA
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
[3] Hlth Res Associates, Seattle, WA USA
关键词
diabetes; patient-reported outcomes; treatment satisfaction; Insulin treatment satisfaction questionnaire (ITSQ); validation;
D O I
10.1007/s11136-007-9209-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Variables associated with treatment satisfaction (TS) can be broadly categorized as precursors, ongoing treatment issues, and treatment outcomes. This study continues the validation process for the Insulin Treatment Satisfaction Questionnaire (ITSQ) while examining relationships between TS and these broader influences. Methods Data (N = 299) were collected in a RCT comparing safety and efficacy of inhaled vs. injectable insulin. Validation examined item and factor characteristics, reliability and validity. Regression analyses examined relationships between overall and domain specific TS and the broader influences. Results Patients with less previous or current treatment burden had greater TS (p < 0.001). Gender, injection fear, functioning, age, compliance and glycemic control were differentially related to TS at the beginning and end of study. Baseline satisfaction was predictive of future TS (p < 0.001). When all significant factors were examined together, lower burden with the current treatment and higher satisfaction with previous treatment continued to be key (p < 0.001) while other factors were no longer significant. Validation findings confirmed the ITSQ was psychometrically sound. Conclusion Over the course of treatment, some factors are associated with TS at treatment start while others are key drivers at treatment end. This suggests that TS is not a static concept.
引用
收藏
页码:1053 / 1063
页数:11
相关论文
共 43 条
  • [1] Aaronson N, 2002, QUAL LIFE RES, V11, P193
  • [2] Development of a preliminary diabetes dietary satisfaction and outcomes measure for patients with type 2 diabetes
    Ahlgren, SS
    Shultz, JA
    Massey, LK
    Hicks, BC
    Wysham, C
    [J]. QUALITY OF LIFE RESEARCH, 2004, 13 (04) : 819 - 832
  • [3] ANDERSON R, 2003, POSTER PRESENTATION
  • [4] Development and validation of the insulin treatment satisfaction questionnaire
    Anderson, RT
    Skovlund, SE
    Marrero, D
    Levine, DW
    Meadows, K
    Brod, M
    Balkrishnan, R
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (04) : 565 - 578
  • [5] [Anonymous], 2000, SCORE VERSION 2 SF36
  • [6] Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease
    Atkinson M.J.
    Sinha A.
    Hass S.L.
    Colman S.S.
    Kumar R.N.
    Brod M.
    Rowland C.R.
    [J]. Health and Quality of Life Outcomes, 2 (1)
  • [7] Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers
    Atkinson, MJ
    Kumar, R
    Cappelleri, JC
    Hass, SL
    [J]. VALUE IN HEALTH, 2005, 8 : S9 - S24
  • [8] The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy-naive Type 2 diabetes: A placebo-controlled, multicentre study
    Bech, P
    Moses, R
    Gomis, R
    [J]. QUALITY OF LIFE RESEARCH, 2003, 12 (04) : 413 - 425
  • [9] Effect of the rapid-acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes
    Bott, U
    Ebrahim, S
    Hirschberger, S
    Skovlund, SE
    [J]. DIABETIC MEDICINE, 2003, 20 (08) : 626 - 634
  • [10] Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience
    Brod, M
    Skovlund, SE
    Wittrup-Jensen, KU
    [J]. QUALITY OF LIFE RESEARCH, 2006, 15 (03) : 481 - 491